162 related articles for article (PubMed ID: 38237804)
1. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.
Meca-Lallana JE; Martínez Yélamos S; Eichau S; Llaneza MÁ; Martín Martínez J; Peña Martínez J; Meca Lallana V; Alonso Torres AM; Moral Torres E; Río J; Calles C; Ares Luque A; Ramió-Torrentà L; Marzo Sola ME; Prieto JM; Martínez Ginés ML; Arroyo R; Otano Martínez MÁ; Brieva Ruiz L; Gómez Gutiérrez M; Rodríguez-Antigüedad Zarranz A; Sánchez-Seco VG; Costa-Frossard L; Hernández Pérez MÁ; Landete Pascual L; González Platas M; Oreja-Guevara C
Neurologia (Engl Ed); 2024 Mar; 39(2):196-208. PubMed ID: 38237804
[TBL] [Abstract][Full Text] [Related]
2. Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
García Merino A; Ramón Ara Callizo J; Fernández Fernández O; Landete Pascual L; Moral Torres E; Rodríguez-Antigüedad Zarrantz A
Neurologia; 2017 Mar; 32(2):113-119. PubMed ID: 27157522
[TBL] [Abstract][Full Text] [Related]
3. Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
García-Merino A; Fernández O; Montalbán X; de Andrés C; Oreja-Guevara C; Rodríguez-Antigüedad A; Arbizu T;
Neurologia; 2013; 28(6):375-8. PubMed ID: 23643683
[TBL] [Abstract][Full Text] [Related]
4. Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y enfermedad cardiovascular aterosclerótica.
Pavía-López AA; Alcocer-Gamba MA; Ruiz-Gastelum ED; Mayorga-Butrón JL; Mehta R; Díaz-Aragón FA; Aldrete-Velasco JA; López-Juárez N; Cruz-Bautista I; Chávez-Mendoza A; Secchi-Nicolás NC; Guerrero-Martínez FJ; Cossio-Aranda JE; Mendoza-Zubieta V; Fanghänel-Salmon G; Valdivia-Proa M; Olmos-Domínguez L; Aguilar-Salinas CA; Dávila-Maldonado L; Vázquez-Rangel A; Pavia-Aubry V; Nava-Hernández MLA; Hinojosa-Becerril CA; Anda-Garay JC; Ríos-Ibarra MOL; Berni-Betancourt AC; López-Cuellar J; Araiza-Garaygordobil D; Rivera-Reyes R; Borrayo-Sánchez G; Tapia-Hernández M; Cano-Nigenda CV; Guerra-López A; Elías-López J; Figueroa-Morales MA; Montaño-Velázquez BB; Velasco-Hidalgo L; Rodríguez-Lozano AL; Pimentel-Hernández C; Baquero-Hoyos MM; Romero-Moreno F; Rodríguez-Vega M
Arch Cardiol Mex; 2022; 92(Supl):1-62. PubMed ID: 35275904
[TBL] [Abstract][Full Text] [Related]
5. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology.
Brieva L; Estruch BC; Merino JAG; Meca-Lallana V; Río J; Rodríguez-Antigüedad A; Agüera E; Ara JR; Luque AA; Garcia CA; Blanco Y; Castillo-Triviño T; Costa-Frossard L; González Platas M; Pascual LL; Llaneza-González M; Ginés MLM; Matías-Guiu J; Meca-Lallana JE; Bilbao MM; Sempere AP; Romero-Pinel L; Saiz A; Moral E
Mult Scler Relat Disord; 2022 Jul; 63():103805. PubMed ID: 35512501
[TBL] [Abstract][Full Text] [Related]
6. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Rae-Grant A; Day GS; Marrie RA; Rabinstein A; Cree BAC; Gronseth GS; Haboubi M; Halper J; Hosey JP; Jones DE; Lisak R; Pelletier D; Potrebic S; Sitcov C; Sommers R; Stachowiak J; Getchius TSD; Merillat SA; Pringsheim T
Neurology; 2018 Apr; 90(17):777-788. PubMed ID: 29686116
[TBL] [Abstract][Full Text] [Related]
7. Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.
Torre Alonso JC; Díaz Del Campo Fontecha P; Almodóvar R; Cañete JD; Montilla Morales C; Moreno M; Plasencia-Rodríguez C; Ramírez García J; Queiro R
Reumatol Clin (Engl Ed); 2018; 14(5):254-268. PubMed ID: 29111261
[TBL] [Abstract][Full Text] [Related]
8. High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis.
Freeman L; Longbrake EE; Coyle PK; Hendin B; Vollmer T
CNS Drugs; 2022 Dec; 36(12):1285-1299. PubMed ID: 36350491
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.
Otero-Romero S; Rodríguez-García J; Vilella A; Ara JR; Brieva L; Calles C; Carmona O; Casanova V; Costa-Frossard L; Eichau S; García-Merino JA; Garcia-Vidal C; González-Platas M; Llaneza M; Martínez-Ginés M; Meca-Lallana JE; Prieto JM; Rodríguez-Antigüedad A; Tintoré M; Blanco Y; Moral E;
Neurologia (Engl Ed); 2021; 36(1):50-60. PubMed ID: 32561334
[TBL] [Abstract][Full Text] [Related]
10. Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.
Teni FS; Machado A; Murley C; He A; Fink K; Gyllensten H; Glaser A; Alexanderson K; Hillert J; Friberg E
Mult Scler Relat Disord; 2023 Jan; 69():104456. PubMed ID: 36529068
[TBL] [Abstract][Full Text] [Related]
11. Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
Col NF; Solomon AJ; Alvarez E; Pbert L; Ionete C; BerriosMorales I; Chester J; Kutz C; Iwuchukwu C; Livingston T; Springmann V; Col HV; Ngo LH
Mult Scler Relat Disord; 2023 Dec; 80():105092. PubMed ID: 37931489
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice patterns in multiple sclerosis management: Mexican consensus recommendations.
Skromne-Eisenberg E; Treviño-Frenk I; Llamosa García Velázquez GL; Quiñones-Aguilar S; Rivas-Alonso V; Maza-Flores M; Macías-Islas MÁ; Llamas-López L; González-Amezquita V; León-Jiménez C; Medina-López Z; Ortiz-Maldonado JF; Santos-Diaz MA; Bertado-Cortés B; Flores-Rivera JJ; Ordóñez-Boschetti L
Mult Scler Relat Disord; 2021 Aug; 53():103053. PubMed ID: 34139461
[TBL] [Abstract][Full Text] [Related]
13. Headache: what to ask, how to examine, and what scales to use. Recommendations of the Spanish society of neurology's headache study group.
Gago-Veiga AB; Camiña Muñiz J; García-Azorín D; González-Quintanilla V; Ordás CM; Torres-Ferrus M; Santos-Lasaosa S; Viguera-Romero J; Pozo-Rosich P
Neurologia (Engl Ed); 2022 Sep; 37(7):564-574. PubMed ID: 36064285
[TBL] [Abstract][Full Text] [Related]
14. Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part II: Obstetric Antiphospholipid Syndrome and Special Situations.
Cáliz Cáliz R; Díaz Del Campo Fontecha P; Galindo Izquierdo M; López Longo FJ; Martínez Zamora MÁ; Santamaria Ortiz A; Amengual Pliego O; Cuadrado Lozano MJ; Delgado Beltrán MP; Ortells LC; Pérez ECC; Rego GD; Corral SG; Varela CF; López MM; Nishishinya B; Navarro MN; Testa CP; Pérez HS; Silva-Fernández L; Taboada VMM
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 2):133-148. PubMed ID: 30686569
[TBL] [Abstract][Full Text] [Related]
15. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
Oh J; Gagné-Brosseau MS; Guenette M; Larochelle C; Lemieux F; Menon S; Morrow SA; Poliquin-Lasnier L; Roy-Hewitson C; Rush C; Trudelle AM; Giacomini PS
Can J Neurol Sci; 2018 May; 45(3):304-312. PubMed ID: 29756588
[TBL] [Abstract][Full Text] [Related]
16. Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis.
Neuberger EE; Abbass IM; Jones E; Engmann NJ
Neurol Ther; 2021 Jun; 10(1):183-196. PubMed ID: 33244713
[TBL] [Abstract][Full Text] [Related]
17. Spanish consensus on the use of natalizumab (Tysabri®)-2013.
Fernández O; García-Merino JA; Arroyo R; Álvarez-Cermeño JC; Izquierdo G; Saiz A; Olascoaga J; Rodríguez-Antigüedad A; Prieto JM; Oreja-Guevara C; Hernández MA; Moral E; Meca J; Montalbán X
Neurologia; 2015 Jun; 30(5):302-14. PubMed ID: 24360652
[TBL] [Abstract][Full Text] [Related]
18. [Consensus document on spasticity in patients with multiple sclerosis. Grupo de Enfermedades Desmielinizantes de la Sociedad Española de Neurología].
Oreja-Guevara C; Montalban X; de Andrés C; Casanova-Estruch B; Muñoz-García D; García I; Fernández Ó;
Rev Neurol; 2013 Oct; 57(8):359-73. PubMed ID: 24081891
[TBL] [Abstract][Full Text] [Related]
19. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
[TBL] [Abstract][Full Text] [Related]
20. Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy.
Villaverde-González R
Degener Neurol Neuromuscul Dis; 2022; 12():1-21. PubMed ID: 35023987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
